Patent · US Active

IL-17A-binding polypeptides

US10934335B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

AFFIBODY AB · SE

Inventors

Fredrik Frejd · Stockholm, SE
Joachim Feldwisch · Tyresö, SE
Susanne Klint · Stockholm, SE
Lindvi Gudmundsdotter · Stockholm, SE

Key dates

Filing date	Jan 12, 2016
Grant date	Mar 2, 2021
Priority date	—
Expiry date	Nov 18, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11 LPNL X16X17X18QX20X21AFIX25 X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.